All News

Microsoft Targets $700 Billion AI Buildout Through 2030 as Workforce Falls
MSF.DE

Microsoft Targets $700 Billion AI Buildout Through 2030 as Workforce Falls

Microsoft plans to invest $700 billion in AI infrastructure through 2030 as it seeks a leading position in the industry. Azure has surpassed $100 billion in...

Goldman Sachs Pledges $500 Million for Small Business AI Institute
GS

Goldman Sachs Pledges $500 Million for Small Business AI Institute

Goldman Sachs announced a $500 million commitment to launch the Small Business AI Institute, an initiative to help entrepreneurs adopt artificial intelligence....

FHB

First Hawaiian's third quarter 2026 revenue beats estimates while NIM expands to 3.30%

First Hawaiian, Inc. reported third quarter 2026 revenue of $230.2 million, narrowly beating analyst estimates, though earnings of $0.52 per share missed the...

ULKER.IS

🔴 Ülker is trading 4.1% down

Ülker is trading 4.11% down at TRY 74.70; no verified company-specific announcement explaining the decline was found. - The supplied price context is for...

HIMX

🟢 Himax Technologies is trading 5.86% up in pre-market; no verified company-specific catalyst identified

Himax Technologies is trading at $11.75 (+5.86%) in pre-market; no verified company-specific catalyst for the October 23 rise was identified. - Search results...

RBCAA

Republic Bancorp's third quarter 2026 EPS of $1.59 misses expectations despite margin expansion to 4.03%

Republic Bancorp reported a 4% increase in third quarter net income to $31.1 million, resulting in a diluted EPS of $1.59, which trailed analyst estimates....

Gentex Corporation missed third quarter 2026 estimates on revenue and margins while lowering full-year 2026 guidance
GNTX

Gentex Corporation missed third quarter 2026 estimates on revenue and margins while lowering full-year 2026 guidance

Gentex reported third quarter 2026 net sales of $647.7 million and earnings per diluted share of $0.43, both falling short of analyst expectations. Performance...

US Futures Fall on AI Spending, Global Worries
Market

US Futures Fall on AI Spending, Global Worries

U.S. stock futures are trading lower, pointing to a cautious open driven by a global risk-off sentiment and investor concerns over spending in the artificial...

MD

🔴 Mednax is trading 4.3% down in pre-market; cause remains unclear

Mednax is trading at $28.27, down -4.3%, before the October 23, 2026 open; the cause remains unclear. - This compares with the provided October 22 close of...

HUDI

🔴 Huadi International Group is trading 8.54% down in pre-market with no confirmed company-specific catalyst

Huadi International Group is trading at $0.49, down 8.54%, after recent losses; no new company-specific announcement was identified for October 23. - The...

ANIX

🟢 Anixa Biosciences is trading 6.1% up in pre-market amid reported CEO share purchase

Anixa Biosciences is trading 6.1% up in pre-market at $2.95 on October 23, 2026; CEO Amit Kumar’s reported purchase may be drawing attention, but its...

Intel CTO Highlights AI Chip Supply Limits, Admits Underinvestment
INTC

Intel CTO Highlights AI Chip Supply Limits, Admits Underinvestment

In a wide-ranging interview, Intel CTO Pushkar Ranade stated that while AI compute demand has tripled annually, the global semiconductor equipment supply chain...

SLM

🔴 Sallie Mae is trading 5% down in pre-market after a Q3 loss and 2026 guidance cut

Sallie Mae is trading at $20.65 (-5.10%) in pre-market after reporting a third-quarter 2026 loss. - The loss was $0.19 per share, versus analysts’ expected...

ENHA

🟢 Enhanced Group is trading 6.19% up in pre-market with no confirmed catalyst

Enhanced Group is trading 6.19% up in pre-market at $1.20 on October 23, 2026, with no specific catalyst confirmed. - No company-specific announcement...

IDEAYA's Lung Cancer Drug Posts Striking Survival Data — But Can a Phase 1 Trial Carry a $3.5 Billion Valuation?
IDYA

IDEAYA's Lung Cancer Drug Posts Striking Survival Data — But Can a Phase 1 Trial Carry a $3.5 Billion Valuation?

Shares of Ideaya Biosciences surged 8% to $39.00 in pre-market trading October 23, defying a broadly weaker market, after the company unveiled survival data...

SpaceX Gets Buy Upgrade as Cloud and Connectivity Lift Target to $250
SPCX

SpaceX Gets Buy Upgrade as Cloud and Connectivity Lift Target to $250

Phillip Securities upgraded Space Exploration Technologies Corp. from Sell to Buy on Friday. The firm raised its price target to $250 from $75, more than...

WQTM

🟢 Tech ETF (WQTM) is trading 2.74% up in pre-market with catalyst unclear

WQTM is trading at $28.10, up 2.74%, rebounding after the prior session’s 4.37% decline; the specific catalyst remains unclear. - Technology shares remain...

TXXD

🟢 TXXD is trading 3.48% up in pre-market

TXXD is trading at $32.63, up 3.48% in pre-market; no clear company-specific announcement or confirmed catalyst was found. - TXXD is the 21Shares 2x Long...

TCAI

🟢 TCAI is trading 2.55% up in pre-market; rebound catalyst unclear

TCAI is trading at $38.99, up +2.55% versus the previous close, with no clear catalyst identified for its pre-market rise. - The October 22 semi-annual report...

IDYA

🟢 Ideaya Biosciences is trading 8% up in pre-market after IDE849 data showed promising anti-tumor activity

Ideaya Biosciences is trading at $39.00, up +7.97%, in pre-market on October 23, 2026, amid updated IDE849 clinical results, the clearest available...